Article Details

UK halts buying AstraZeneca COVID drug Evusheld on efficacy concerns versus Omicron

Retrieved on: 2022-08-16 10:34:41

Tags for this article:

Click the tags to see associated articles and topics

UK halts buying AstraZeneca COVID drug Evusheld on efficacy concerns versus Omicron. View article details on HISWAI: https://seekingalpha.com/news/3873494-uk-halts-buying-astrazeneca-covid-19-drug-evusheld-on-efficacy-concerns-versus-omicron%3Fsource%3Dcontent_type%253Areact%257Cfirst_level_url%253Amarket-news%257Csection_asset%253Amain

Excerpt

The U.K. has halted procurement of AstraZeneca's (AZN) COVID-19 therapy Evusheld citing "insufficient data" on the duration of protection the drug ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up